Table 4.
Etiology | White Male 2016 v 2004 | White Male 2016 v 2015 | White Female 2016 v 2004 | White Female 2016 v 2015 | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
Change | p-value | Change | p-value | Change | p-value | Change | p-value | |
HCV | −60% | <0.0001 | −19% | 0.0325 | −51% | 0.0023 | −18% | 0.0754 |
ALD | 40% | <0.0001 | 23% | 0.0031 | 59% | <0.0001 | 11% | 0.4761 |
NASH | 115% | <0.0001 | 30% | 0.0011 | 75% | <0.0001 | 15% | 0.2499 |
HCC & HCV | 76% | <0.0001 | −30% | <0.0001 | 147% | <0.0001 | −34% | 0.0032 |
HCV & ALD | −50% | <0.0001 | −13% | 0.3364 | −33% | 0.7150 | −11% | 0.5297 |
HCC& NASH | 877% | <0.0001 | 32% | 0.0594 | 1042% | 0.0001 | −10% | 0.5413 |
HCC & ALD | 121% | <0.0001 | −12% | 0.4873 | n/a | 0.8867 | −38% | 0.2245 |
Etiology | Hispanic Male 2016 v 2004 | Hispanic Male 2016 v 2015 | Hispanic Female 2016 v 2004 | Hispanic Female 2016 v 2015 | ||||
|
||||||||
Change | p-value | Change | p-value | Change | p-value | Change | p-value | |
HCV | −48% | 0.1939 | −17% | 0.6369 | −69% | 0.0003 | −26% | 0.9582 |
ALD | 26% | 0.0099 | 4% | 0.4803 | 62% | 0.1808 | 1% | 0.2915 |
NASH | 240% | <0.0001 | 37% | 0.0791 | 122% | 0.0041 | 19% | 0.3648 |
HCC & HCV | 109% | 0.0007 | −9% | 0.9536 | 560% | 0.0060 | −18% | 0.8301 |
HCV & ALD | −50% | 0.1930 | 2% | 0.6563 | −59% | 0.1017 | 33% | 0.2008 |
HCC & NASH | 720% | 0.0175 | −7% | 0.9749 | 749% | 0.0264 | 10% | 0.5864 |
HCC & ALD | 235% | 0.0045 | 38% | 0.1680 | n/a | 0.9834 | −59% | 0.4801 |
Etiology | AA Male 2016 v 2004 | AA Male 2016 v 2015 | AA Female 2016 v 2004 | AA Female 2016 v 2015 | ||||
|
||||||||
Change | p-value | Change | p-value | Change | p-value | Change | p-value | |
HCV | −36% | 0.1625 | 14% | 0.6539 | −43% | 0.0449 | −26% | 0.0858 |
ALD | 88% | 0.0594 | 53% | 0.1986 | −20% | 0.5601 | −13% | 0.4280 |
NASH | −3% | 0.8627 | −9% | 0.7752 | 157% | 0.1622 | 34% | 0.7373 |
HCC & HCV | 171% | 0.0004 | −23% | 0.1325 | 50% | 0.3749 | −28% | 0.0823 |
HCV & ALD | −19% | 0.8326 | 0% | 0.9185 | 8% | 0.9484 | 19% | 0.9778 |
HCC & NASH | n/a | 0.9850 | 0% | 0.9803 | n/a | 0.9906 | −38% | 0.4857 |
HCC & ALD | −19% | 0.9106 | −16% | 0.7258 | n/a | 0.9999 | −100% | 0.9854 |
Etiology | Asian Male 2016 v 2004 | Asian Male 2016 v 2015 | Asian Female 2016 v 2004 | Asian Female 2016 v 2015 | ||||
|
||||||||
Change | p-value | Change | p-value | Change | p-value | Change | p-value | |
HCV | −50% | 0.1456 | −12% | 0.7087 | −55% | 0.3071 | −47% | 0.2713 |
ALD | 223% | 0.0198 | −5% | 0.8352 | n/a | 0.9924 | 321% | 0.1741 |
NASH | 597% | 0.0482 | 76% | 0.2544 | n/a | 0.9850 | 96% | 0.1303 |
HCC & HCV | 9% | 0.5996 | 2% | 0.9961 | 31% | 0.4726 | 47% | 0.4249 |
HCV & ALD | 0% | 0.9228 | −12% | 0.8857 | n/a | 0.9965 | n/a | 0.9952 |
HCC & NASH | n/a | 0.9762 | −67% | 0.1025 | n/a | 0.9918 | −30% | 0.7946 |
HCC & ALD | −50% | 0.4894 | 32% | 0.7776 | n/a | 0.9999 | n/a | 0.9999 |
Percent change computed from observed counts over time and p-values computed from multinomial regression analysis within each ethnicity and gender; n/a indicates percent change not computed due to zero observations in divisor
AA African Americans, HCV Hepatitis C virus, ALD Alcoholic liver disease, NASH Non-alcoholic steatohepatitis, HCC Hepatocellular carcinoma